REVERSE DOCKING AND PHARMACOPHORE MAPPING AS TOOLS TO FIND NEW PHARMACOLOGICAL TARGETS FOR NATURAL COMPOUNDS
PDF (Español (España))

How to Cite

Maldonado rojas, W., Noguera Oviedo, K., & Olivero Verbel, J. (2023). REVERSE DOCKING AND PHARMACOPHORE MAPPING AS TOOLS TO FIND NEW PHARMACOLOGICAL TARGETS FOR NATURAL COMPOUNDS. Revista De La Academia Colombiana De Ciencias Exactas, Físicas Y Naturales, 36(140), 411–420. https://doi.org/10.18257/raccefyn.36(140).2012.2481

Downloads

Download data is not yet available.

Métricas Alternativas


Dimensions

Abstract

The resurgence of natural products on the drug discovery scene has its basis on the introduction of new approaches, technologies and methodologies, including the computer-aided design of bioactive molecules. TarFisDock and PharmMapper severs are computational tools employed for the search of potential drug targets for organic ligands. This work shows an example of application for these servers. The obtained results suggested that nature-derived molecules, such as ascididemine (Didemnum sp. Tunicado), peyssonol B (Peyssonnelia sp), asiatic acid (Centella asiatica) and the docosahexaenoic acid (fish oil), have as targets the dihydroorotate dehydrogenase, myeloperoxidase, retinoic acid receptor beta, and aldose reductase, respectivaley. These proteins have been related to diverse diseases and offer a theoretical explanation for some of the beneficial effects reported for evaluated molecules.

https://doi.org/10.18257/raccefyn.36(140).2012.2481

Keywords

AutoDock Vina | natural products | PharmMapper | pharmacophore | TarFisDock | Molecular docking
PDF (Español (España))

References

Appleton, d. r.; norrie pearce, A.; Copp, b. r. 2010. Anti-tuberculosis natural products: synthesis and biological evaluation of pyridoacridine lkaloids related to ascididemin. Tetrahedron, 66(27/28):4977-4986.

butler, M. s.; buss, A. d. 2006. Natural products -The future scaffolds for novel antibiotics?. Biochem. Pharmacol. 71(7):919-929.

Cai, J.; han, C.; hu, t.; Zhang, J.; Wu, d.; Wang, f., liu, y.; ding, J.; Chen, K.; yue, J.; shen, X.; Jiang, h. 2006. Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking,

Enzymatic assay, and x-ray crystallography validation. Protein Sci. 15(9):2071-2081.

Chen, y. Z.; Ung, C. y. 2002. Computational method for drug target search and application in drug discovery. J. Theor. Comput. Chem. 1(1):1-12.

Chomańska, U.; Kraśnicki, P.; Proniewska-Skretek, E.; Mariak, Z. 2010. Acute phacomorphic glaucoma in patient with diabetes mellitus type 1-case report. Klin. Oczna. 112(7-9):240-242.

Cordell, g. 2000. Biodiversity and drug discovery a symbiotic relationship. Phytochemistry 55(6):463-480.

Delano, W. l. The PyMOL molecular graphics system. DeLano Scientific LLC. 1998-2003. San Carlos, CA, USA. http://www.pymol.org.

Frisch, M. J.; trucks, g. W.; schlegel, h. r.; scuseria, g. e.; robb, M. A.; Cheeseman, J. r.; Montgomery, Jr. J. A.; vreven, t.; Kudin, K. n.; burant, J. C.; Millam, J. M.; Iyengar, s. s.; tomasi, J.; barone, v.; Mennucci, b.; Cossi, M.; scalmani, g.; rega, n.; petersson, g. A.; nakatsuji, h.; hada, M.; ehara, M.; toyota, K.; fukuda, r.; hasegawa, J.; Ishida, M.; nakajima, t.; honda, y.; Kitao, o.; nakai, h.; Klene, M.; li, X.; Knox, J. e.; hratchian, h. p.; Cross, J. b.; bakken, v.; Adamo, C.; Jaramillo, J.; gomperts, r.; stratmann, r. e.; yazyev, o.; Austin, A. J.; Cammi, r.; pomelli, C.; ochterski, J. W.; Ayala, p. y.; Morokuma, K.; voth, g. A.; salvador, p.; dannenberg, J. J.; Zakrzewski, v. g.; dapprich, s.; daniels, A. d.; strain, M. C.; farkas, o.; Malick, d. K.; rabuck, A. d.; raghavachari, K.; foresman, J. b.; ortiz, J. v.; Cui, Q.; baboul, A. g.; Clifford, s.; Cioslowski, J.; stefanov, b. b.; liu, g.; liashenko, A.; piskorz, p.; Komaromi, I.; Martin, r. l.; fox, d. J.; Keith, t.; Al-laham, M. A.; peng, C. y.; nanayakkara, A.; Challacombe, M.; gill, p. M. W.; Johnson, b.; Chen, W.; Wong, M. W.; gonzalez, C.; pople, J. A. Gaussian03.

Gaussian, Inc.: Pittsburgh, PA, USA, 2003. gad, s. C. 2007. Preclinical development handbook: ADME and biophar maceutical properties.; Wiley-Interscience: Cary, North Carolina. DOI 10.1002/9780470249031.

Ganesan, A. 2008. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol. 12(3):306-317.

Gao, Z.; li, h.; Zhang, h.; liu, X.; Kang, l.; luo, X.; Zhu, W.; Chen, K.; Wang, X.; Jiang, h. 2008. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics, 9:104.

Guha, r.; howard, M. t.; hutchison, g. r.; Murray-rust, p.; rzepa, h.; steinbeck, C.; Wegner J. K.; Willighagen, e. 2006. The blue obelisk -- Interoperability in chemical informatics. J. Chem. Inf. Model. 46(3):991-998.

Harriman, J.; deleavey, g.; lambropoulos, A.; deslongchamps, g. 2007. Reverse-docking study of the organocatalyzed asymmetric Strecker hydrocyanation of aldimines and ketimines. Tetrahedron, 63(52):13032-13038.

Harvey, A. l. 2007. Natural products as a screening resource. Curr. Opin. Chem. Biol. 11(5):480-484.

Harvey, A. l. 2008. Natural products in drug discovery. Drug Discov. Today. 13(19/20):894-901.

Jain, s.; Chincholikar, A. 2004. Pharmacophore Mapping And Drug Design. Indian J. Pharm. Sci. 66(1):11-17.

Jeong, C.; bode, A. M.; pugliese, A.; Cho,y. y.; Kim, h. g.; shim, J. h.; Jeon, y. J.; li, h.; Jiang, h.; dong, Z. 2009. [6]-Gingerol suppresses colon cancer growth by targeting Leukotriene A4 Hydrolase. Cancer Res. 69(13):5584-5591.

Ji, h.; li, X.; Zhang, h. 2009. Natural products and drug discovery. EMBO reports. 10(3):194-200.

Kada, n.; suzuki, t.; Aizawa, K.; Matsumura, t.; Ishibashi, n.; suzuki, n.; takeda, n.; Munemasa, y.; sawaki, d.; Ishikawa, t.; nagai, r. 2007. Acyclic retinoid inhibits neointima formation through retinoic acid receptor beta-induced apoptosis. Arterioscler. Thromb. Vasc. Biol. 27(7):1535-1541.

Kämper, A; Apostolakis, J.; rarey, M.; Marian , C.; lengauer, t. 2006. Fully automated flexible docking of ligands into flexible synthetic receptors using forward and inverse docking strategies. J. Chem. Inf. Model.46(2):903-911.

Kaneski, C. r.; Moore, d. f.; ries, M.; Zirzow, g. C.; schiffmann, r. 2006. Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease. Neurology. 67(11):2045-2047.

Kansal, n.; silakari, o.; ravikumar, M. 2010. Three dimensional pharmacophore modelling for c-Kit receptor tyrosine kinase inhibitors. Eur. J. Med. Chem. 45(1):393-404.

Kapetanovic, I. M. 2008. Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chem. Biol. Interact. 171(2):165-176.

Kulkarni, o. p.; sayyed, s. g.; Kantner, C.; ryu, M.; schnurr, M.; sárdy, M.; leban, J.; Jankowsky, r.; Ammendola, A.; doblhofer, r.; Anders, h. J. 2010. 4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice. Am. J. Pathol. 176(6):2840- 2847.

Kumar, K.; Waldmann, h. 2009. Synthesis of natural product inspired compound collections. Angew. Chem. Int. Ed. Engl. 48(18):3224-42.

lam, K. 2007. New aspects of

lane, A. l.; Mular, l.; drenkard , e. J.; shearer, t. l.; engel, s.; fredericq, s.; fairchild, C. r.; prudhomme, J.; roch , K.; hay, M. e.; Aalbersberg, W.; Kubanek, J. 2010. Ecological leads for natural product discovery: novel sesquiterpene hydroquinones from the red macroalga Peyssonnelia sp. Tetrahedron, 66(2):455-461.

Li, h.; gao, Z.; Kang, l.; Zhang, h.; yang, K.; yul, K.; Zhul, W.; Chen,VK.; shen, J.; Wang, X.; Jiang, h. 2006. TarFisDock: a web serverVfor identifyingVdrug targets with docking approach. Nucl. Acids Res.V34(2):219-224.

Liu, X.; ouyang, s.; yu, b.; liu, y.; huang, K.; gong, J.; Zheng, s.; li, Z.; Jiang, h. 2010. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucl. Acids Res. 38(2):609-614.

Mandal, s.; Moudgil, M.; Mandal, s. K. 2009. Rational drug design. Eur. J. Pharmacol. 625(1/3):90-100.

Matsumoto, s.; biggs, J.; Copp, b. r.; holden, J. A.; barrows, l. r. 2003. Mechanism of ascididemin-Induced cytotoxicity. Chem. Res. Toxicol. 16(2):113-122.

Mattingly, C. 2009. Chemical databases for environmental health and clinical research. Toxicol. Lett. 186(1):62-65.

McChesney, J.; venkataraman, s.; henri, t. 2007. Plant natural products: Back to the future or into extinction?. Phytochemistry, 68(14):2015-2022.

Mukherjee, s.; nagar, s.; Mullick, s.; Mukherjee, A.; saha, A. 2008. Pharmacophore mapping of arylbenzothiophene derivatives for MCF cell inhibition using classical and 3D space modeling approaches. J. Mol. Graph. Model. 26(5):884-892.

Mullen, A.; loscher, C. e.; roche, h. M. 2010. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J. Nutr. Biochem. 21(5):444-450.

Olivero-verbel, J.; Cabarcas-Montalvo, M.; ortega-Zúñiga, C. 2010. Theoretical targets for TCDD: A bioinformatics approach. Chemosphere, 80(10):1160-1166.

Pandey, J.; sharma, A.; tiwari, v. K.; dube, d., ramachandran, r.; Chaturvedi, v.; sinha, s.K.; Mishra, n.n.; shukla, p.K.; tripathi, r. p. 2009. Solution phase synthesis of a library of carbapeptide analogues based on glycosylamino acid scaffolds, their in silico screening and antimicrobial evaluation. J. Comb. Chem. 11(3):422-427.

Patil, s. p.; Maki, s.; Khedkar, s. A., rigby, A. C.; Chan, C. 2010. Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance. J. Nat. Prod. 73(7):1196-1202.

Ramana, K. v. ; tammali, r. ; srivastava, s. K. 2010. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells. Mol. Cancer The. 9(4):813-824.

RCSB PDB Protein Data Bank . www.pdb.org/pdb/home/home.do.

Rishton, g. M. 2008. Natural products as a robust source of new drugs and drug leads: past successes and present day issues. Am. J. Cardiol. 101(10A):44D-49D.

Rudolph, v.; Andrié, r. p.; rudolph, t. K.; friedrichs, K.; Klinke, A.; hirsch-hoffmann, b.; schwoerer, A. p.; lau, d.; fu, X. M.; Klingel, K.; sydow, K.; didié, M.; seniuk, A.; von leitner, e.; szoecs, K.; schrickel, J. W.; treede, h.; Wenzel, U.; lewalter, t.; nickenig, g.; Zimmermann, W.; Meinertz, t.; böger, r. h.; reichenspurner, h.; freeman, b. A.; eschenhagen, t.; ehmke, h.; hazen, s. l.; Willems, s.; baldus, s. 2010. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat. Med. 16(4):470-474.

Schneidman-duhovny, d.; dror, o.; Inbar, y.; nussinov, r.; Wolfson, h. J. 2008. PharmaGist: a webserver for ligand-based pharmacophore detection. Nucl. Acids Res. 36(2):223-228.

SYBYL molecular modeling software, Version 8.1. 2007. Tripos, St. Louis, MO, U.S.A.

Tang, y.; Zhu, W.; Chen, K.; Jiang, h. 2006. New technologies in computer-aided drug design: toward target identification and new chemical entity discovery. Drug Discov. Today Technol. 3(3):307-313.

Trott, o.; olson, A. J. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 31(2):455-461.

Vita, J. A.; brennan, M. l.; gokce, n.; Mann, s. A.; goormastic, M.; shishehbor, M. h.; penn, M.s.; Keaney, J. f.; hazen, s. l. 2004. Serum Myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 110:1134-1139.

Wermuth, C. g.; ganellin, C. r.; lindberg, p.; Mitscher, l. A. 1998. Glossary of terms used in medicinal chemistry. Pure Appl. Chem. 70(5):1129-1143.

Wild, d.; Wiggins, g. 2006. Challenges for chemoinformatics education in drug discovery. Drug Discov. Today. 11(9/10):436-439.

Wilk, W.; Zimmermann, t. J.; Kaiser, M.; Waldmann, h. 2010. Principles, implementation, and application of biology-oriented synthesis (BIOS). Biol Chem. 391(5):491-49Wolber, g.; langer, t. 2005. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem. Inf. Model. 45(1):160-169.

Wolfe, M. s.; selkoe, d. J. 2010. Giving Alzheimer’s the old one-two. Cell. 142(2):194-196.

Yadav, U. C. ; srivastava, s. K.; ramana, K. v. 2010. Understanding the role of aldose reductase in ocular inflammation. Curr. Mol. Med. 10(6):540-549.

Zameitat, E.; Freymark, G.; Dietz, C. D.; Löffler, M.; Bölker, M. 2007. Functional expression of human dihydroorotate dehydroge-nase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo. Appl. Environ. Microbiol. 73(10):3371-3379.

Chen, Z., Wang, X., Zhu, W., Cao, X., tong, l., li, h., Xie, h., Xu, y., tan, s., Kuang, d., ding, J., Qian, X. 2011. Acenaphtho [1,2-b] pyrrole-Based selective fibroblast growth factor receptors 1 (FGFR1) Inhibitors: design, synthesis, and biological Activity. J. Med. Chem. 54(11):3732-3745

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales